Kingshuk Das

发表

Assessing the necessity of confirmatory testing for exome sequencing results in a clinical molecular diagnostic laboratory

Eric Vilain, Stanley F. Nelson, Wayne W. Grody, 2014, Genetics in Medicine.

Clinical exome sequencing for genetic identification of rare Mendelian disorders.

Eric Vilain, Samuel P Strom, Michelle Fox, 2014, JAMA.

Increased prevalence of two mitochondrial DNA polymorphisms in functional disease: Are we describing different parts of an energy-depleted elephant?

R. Boles, E. Zaki, Sawona Biswas, 2015, Mitochondrion.

Instability of a dinucleotide repeat in the 3′‐untranslated region (UTR) of the microsomal prostaglandin E synthase‐1 (mPGES‐1) gene in microsatellite instability‐high (MSI‐H) colorectal carcinoma

Joshua L. Deignan, W. Grody, H. Herschman, 2015, Molecular Oncology.

Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.

Joshua L. Deignan, J. Rotter, W. Grody, 2012, Pharmacogenomics.

Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study.

S. Dry, D. Enzmann, M. Kuo, 2017, Radiology.

Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer

R. Nussbaum, S. Lincoln, A. Kurian, 2020, JAMA network open.

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

J. Rotter, W. Grody, M. Goodarzi, 2012, Expert review of molecular diagnostics.

Translational utility of next-generation sequencing.

Jian-Bing Fan, Jimmy Lin, D. Grosu, 2013, Genomics.

Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.

Joshua L. Deignan, J. Rotter, W. Grody, 2012, Pharmacogenomics.

Clinical exome sequencing for genetic identification of rare Mendelian disorders.

Joshua L. Deignan, S. Nelson, W. Grody, 2014, JAMA.